Key result
Kolaviron pre-treatment mitigates ischemia-reperfusion injury in rat hearts by reducing oxidative stress.
Why the study?
Does Kolaviron mitigate ischemic/reperfusion injury in experimental animal models?
Does Kolaviron mitigate ischemic/reperfusion injury in experimental animal models?
p-value: p=< 0.05
Kolaviron demonstrates cardioprotective effects against ischemia/reperfusion injury in rat models by reducing oxidative stress and modulating apoptotic pathways.
OBJECTIVE: The study was designed to investigate the ameliorative effect of Kolaviron (KV) on ischemic/reperfusion injury in experimental animal models. MATERIALS AND METHODS: . After 4 weeks of KV administration, hearts were excised and mounted on the working heart perfusion system. Western blot analysis for protein expression was carried out on frozen heart samples. RESULTS: < 0.05) reduction in the activity of catalase, superoxide dismutase, and glutathione peroxidase with concomitant reduction in oxygen radical absorbance capacity in ischemic rat heart of control compared to group pre-treated with KV, respectively. Similarly, intracellular reactive oxygen species and malondialdehyde were significantly elevated in control compared to KV pre-treated rats. KV significantly increased total Akt/protein kinase B (PKB), phosphorylated Akt/PKB at serine 473 and also caused a significant reduction in p38 mitogen-activated protein kinase, Caspase 3, and cleaved poly adenosine diphosphate ribose polymerase. CONCLUSION: Taken together, KV offered significant cardioprotection via free radical scavenging activity and upregulation of pro-survival pathway.
No takes yet. Share an insight, caveat, or question.
Oyagbemi et al. (2016) studied ischemic/reperfusion injury. Kolaviron vs. control was evaluated on activity of catalase, superoxide dismutase, and glutathione peroxidase (p=< 0.05). Kolaviron pre-treatment significantly mitigated ischemic/reperfusion injury in rat hearts by reducing oxidative stress and upregulating pro-survival pathways (P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: